来源:金融界网
健友股份公告,公司子公司香港健友向美国FDA申报的异舒泛蓝注射液,规格5ml:50mg的ANDA申请获得批准。本品皮下给药,用于注射部位的淋巴管显影。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.